Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the Potential Treatment of Onychomycosis-Reference-Cited by-同舟云学术

Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the Potential Treatment of Onychomycosis

Published:2006-06-27 Issue:15 Volume:49 Page:4447-4450
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Baker Stephen J.¹,Zhang Yong-Kang¹,Akama Tsutomu¹,Lau Agnes¹,Zhou Huchen¹,Hernandez Vincent¹,Mao Weimin¹,Alley M. R. K.¹,Sanders Virginia¹,Plattner Jacob J.¹

Affiliation:

1. Anacor Pharmaceuticals Inc., 1060 East Meadow Circle, Palo Alto, California 94303

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0603724

Reference18 articles.

1. Epidemiology, clinical presentation and diagnosis of onychomycosis

2. Treatment Failures and Relapses in Onychomycosis: A Stubborn Clinical Problem

3. Large-Scale Epidemiological Study of the Causal Agents of Onychomycosis: Mycological Findings From the Multicenter Onychomycosis Study of Terbinafine

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an effective meropenem/KPC-2 inhibitor combination to combat infections caused by carbapenem-resistant Klebsiella pneumoniae;International Journal of Antimicrobial Agents;2024-09

2. Pass the boron: benzoxaboroles as antiparasite drugs;Trends in Parasitology;2024-09

3. On the mode of anti-C. albicansactivity of a bis(benzoxaborole) analogue of Tavaborole;2024-07-30

4. Removing Neighboring Ring Influence in Monocyclic B–OH Diazaborines: Properties and Reactivity as Phenolic Bioisosteres with Dynamic Hydroxy Exchange;Journal of the American Chemical Society;2024-07-03

5. Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients;Annals of Clinical Microbiology and Antimicrobials;2024-03-18